Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Turning Point Therapeutic...

    NASDAQ: TPTX · Real-Time Price · USD
    75.49
    0.09 (0.12%)
    At close: Aug 15, 2022, 10:00 PM

    Turning Point Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 1.03M 6.08M 30.85M 30.83M 55.37M 50.21M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 1.03M 6.08M 30.85M 30.83M 55.37M 50.21M
    Operating Income
    		 -342.63M -276.2M -237.81M -207.3M -159.18M -135.26M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -342.31M -275.49M -236.55M -205.48M -156.86M -132.08M
    Net Income
    		 -342.31M -275.49M -236.55M -205.48M -156.86M -132.08M
    Selling & General & Admin
    		 96.7M 76.17M 75.85M 69.05M 62.15M 53.56M
    Research & Development
    		 248.9M 206.77M 192.98M 169.08M 152.4M 131.91M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 345.6M 282.94M 268.83M 238.13M 214.55M 185.46M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 345.6M 282.94M 268.83M 238.13M 214.55M 185.46M
    Income Tax Expense
    		 2.29M 1.39M 904K 712K 384K n/a
    Shares Outstanding (Basic)
    		 49.7M 49.61M 49.5M 49.43M 49.2M 48.92M
    Shares Outstanding (Diluted)
    		 49.7M 49.61M 49.5M 49.43M 49.2M 48.92M
    EPS (Basic)
    		 -6.9 -5.56 -4.79 -4.23 -3.31 -2.99
    EPS (Diluted)
    		 -6.9 -5.56 -4.79 -4.23 -3.31 -2.99
    EBITDA
    		 -337.25M -270.9M -232.58M -202.18M -154.16M -129.64M
    EBIT
    		 -342.63M -276.2M -201.76M -123.31M -56.66M n/a
    Depreciation & Amortization
    		 5.05M 4.59M 3.97M 3.3M 2.69M 2.44M

    Add to Watchlist